Kiley Juergens Wealth Management’s GSK GSK Stock Holding History

Kiley Juergens Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,072	Closed	-$254K	–	280
2018 Q3	$254K	Buy	5,072 +2,822	+125%	+$143K	0.19%	83
2018 Q2	$113K	Buy	+2,250	New	+$113K	0.1%	122
2018 Q1	–	Sell	-1,521	Closed	-$67K	–	293
2017 Q4	$67K	Buy	+1,521	New	+$70.3K	0.06%	169

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Kiley Juergens Wealth Management's GSK Position: Q4 2018 in Review

Kiley Juergens Wealth Management sold out of GSK (GSK) in Q4 2018, closing a stake of 5,072 shares — an estimated $254K sold.

Kiley Juergens Wealth Management first reported a position in GSK in Q4 2017 and held it in 3 quarters. The position peaked at $254K in Q3 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Kiley Juergens Wealth Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Kiley Juergens Wealth Management sold 5,072 GSK shares in Q4 2018, an estimated $254K.
Kiley Juergens Wealth Management first reported a position in GSK in Q4 2017 and held it in 3 quarters.
Kiley Juergens Wealth Management's GSK position peaked at $254K in Q3 2018.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Kiley Juergens Wealth Management's 13F filing for Q4 2018, filed 15 Jan 2019.